Literature DB >> 1822561

Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin.

M Hamamura1, G Leng, P C Emson, H Kiyama.   

Abstract

1. The expression of c-fos mRNA in the rat hypothalamus was examined by in situ hybridization following systemic administration of cholecystokinin (CCK), a procedure known to activate magnocellular oxytocin neurons but not magnocellular vasopressin neurones. 2. Conscious male rats were given a single I.P. injection of 50 micrograms/kg CCK, c-fos mRNA signal was apparent in the supraoptic and paraventricular nuclei in rats killed 10 min after injection but not in uninjected or saline-(vehicle) injected rats. The density of c-fos mRNA at both sites was further elevated in rats killed 30 min or 60 min following injection, and was absent in rats killed 4 h after injection. 3. In the paraventricular nucleus the most dense expression of c-fos mRNA following CCK administration was in the medial, mainly parvocellular portion of the nucleus, in an area corresponding to the distribution of corticotrophin-releasing factor mRNA determined by in situ hybridization in adjacent sections. 4. The I.P. injection of CCK increased plasma oxytocin concentrations, measured by specific radioimmunoassay from 13 +/- 5 pg/ml in control rats to 107 +/- 9 pg/ml in the rats killed 10 min after injection, a similar response to that observed previously in urethane-anaesthetized rats. 5. In each of six urethane-anaesthetized rats, recordings were made from single neurones in the supraoptic nucleus, identified antidronomically as projecting to the posterior pituitary and identified electrophysiologically as putative oxytocin neurones. Following I.P. injection of 50 micrograms/kg CCK, the neurones increased their firing rate by a mean of 1.3 +/- 0.2 spikes/s averaged over the 10 min following injection. 6. From the appearance of c-fos mRNA in supraoptic neurones following CCK administration we conclude that this message is expressed in magnocellular oxytocin neurones, since vasopressin neuronal activity and vasopressin release is known to be unaffected by this stimulus, and since the supraoptic nucleus contains essentially only oxytocin neurones and vasopressin neurones. 7. We conclude that c-fos mRNA expression can be induced in supraoptic oxytocin neurones following brief and modest episodes of electrical activation, suggesting that c-fos may be involved in the gene regulation of these neurones under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822561      PMCID: PMC1179920          DOI: 10.1113/jphysiol.1991.sp018865

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

1.  Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene.

Authors:  J R Naranjo; B Mellström; M Achaval; P Sassone-Corsi
Journal:  Neuron       Date:  1991-04       Impact factor: 17.173

2.  Induction of c-fos-like protein in spinal cord neurons following sensory stimulation.

Authors:  S P Hunt; A Pini; G Evan
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

3.  Role of ion flux in the control of c-fos expression.

Authors:  J I Morgan; T Curran
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

Review 4.  Stimulus-transcription coupling in neurons: role of cellular immediate-early genes.

Authors:  J I Morgan; T Curran
Journal:  Trends Neurosci       Date:  1989-11       Impact factor: 13.837

5.  Mapping patterns of c-fos expression in the central nervous system after seizure.

Authors:  J I Morgan; D R Cohen; J L Hempstead; T Curran
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

6.  Oxytocin neurons in the rat hypothalamus exhibit c-fos immunoreactivity upon osmotic stress.

Authors:  L Giovannelli; P J Shiromani; G F Jirikowski; F E Bloom
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

7.  Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

8.  Effects of chemoreceptor and baroreceptor stimulation on the discharge of hypothalamic supraoptic neurones in rats.

Authors:  M C Harris
Journal:  J Endocrinol       Date:  1979-07       Impact factor: 4.286

9.  Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium.

Authors:  C A Bondy; R T Jensen; L S Brady; H Gainer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  The effects of neural stalk stimulation upon firing patterns in rat supraoptic neurones.

Authors:  G Leng
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

View more
  12 in total

1.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

2.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

3.  Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.

Authors:  Mitsuko Hamamura; Hidetoshi Ozawa; Miwako Ozaki; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2010-08-03       Impact factor: 3.575

4.  Selective changes in the shapes of parasagittal bands of Aldoc (Zebrin) mRNA in the rat vermis of the cerebellum after repeated methamphetamine injections.

Authors:  Mitsuko Hamamura; Signori Watanabe; Yasuyuki Fukumaki
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

5.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

6.  Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum.

Authors:  Mitsuko Hamamura; Naotsugu Hirata; Kazuhiko Sawada; Takahide Shuto; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

7.  Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.

Authors:  S M Luckman; M Hamamura; I Antonijevic; S Dye; G Leng
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

Authors:  J Chen; K A Scott; Z Zhao; T H Moran; S Bi
Journal:  Neuroscience       Date:  2008-03-03       Impact factor: 3.590

9.  Analysis of bursting responses of oxytocin neurones in the rat in late pregnancy, lactation and after weaning.

Authors:  Q B Jiang; J B Wakerley
Journal:  J Physiol       Date:  1995-07-01       Impact factor: 5.182

10.  Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model.

Authors:  Adedolapo Adebakin; Jenna Bradley; Sarah Gümüsgöz; Elizabeth J Waters; Catherine B Lawrence
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.